Digoxin, an Overlooked Agonist of RORγ/RORγT
Digoxin was one of the first identified RORγT receptor inverse agonists inhibiting the differentiation of Th17 cells. However, this compound exhibits inhibitory activity at relatively high concentrations that mediate cytotoxic effects. We previously identified several cardenolides that are structura...
Main Authors: | Kaja Karaś, Anna Sałkowska, Marta Sobalska-Kwapis, Aurelia Walczak-Drzewiecka, Dominik Strapagiel, Jarosław Dastych, Rafał A. Bachorz, Marcin Ratajewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01460/full |
Similar Items
-
The application of machine learning methods to the prediction of novel ligands for RORγ/RORγT receptors
by: Rafał A. Bachorz, et al.
Published: (2023-01-01) -
Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner
by: Hongye Zou, et al.
Published: (2023-04-01) -
Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation
by: Nannan Sun, et al.
Published: (2018-12-01) -
Identification of the Natural Steroid Sapogenin Diosgenin as a Direct Dual-Specific RORα/γ Inverse Agonist
by: Patrik F. Schwarz, et al.
Published: (2022-08-01) -
Eosinophils Contribute to Oral Tolerance via Induction of RORγt-Positive Antigen-Presenting Cells and RORγt-Positive Regulatory T Cells
by: Shunjiro Kurihara, et al.
Published: (2024-01-01)